Cipla in spotlight after acquiring novel anti-infective Elores

Image
Capital Market
Last Updated : Oct 18 2019 | 9:04 AM IST

Cipla announced the acquisition of a novel and patented anti-infective product, Elores, from Venus Remedies (VRL) for the Indian market to further strengthen its presence in the branded Indian critical care space and as a part of its agenda to contribute to the fight against Anti-Microbial Resistance (AMR). The announcement was made after market hours yesterday, 17 October 2019.

Ambuja Cements and Reliance Industries will unveil their quarterly results today, 18 October 2019.

Zee Entertainment Enterprises' consolidated net profit rose 6.87% to Rs 413.23 crore on 7.62% rise in total income to Rs 2190.13 crore in Q2 September 2019 over Q2 September 2018. The result was announced after market hours yesterday, 17 October 2019.

South Indian Bank net profit rose 20.46% to Rs 84.48 crore on 18.81% rise in total income to Rs 2203.18 crore in Q2 September 2019 over Q2 September 2018. The result was announced after market hours yesterday, 17 October 2019.

Indiabulls Housing Finance issued an offer to all debenture holder(s) for pre-mature redemption of its NCDs maturing in November and December 2019 at par. The company will also evaluate further pre-mature redemption of its NCDs from time to time. The announcement was made after market hours yesterday, 17 October 2019.

NOCIL said that the company has after achieving mechanical completion started the trial runs effective 17 October 2019 at the company's plant situated at Dahej, in the state of Gujarat. The announcement was made after market hours yesterday, 17 October 2019.

Alicon Castalloy has signed multi-year contracts aggregating Rs 810 crore with leading global OEMs and Tier 1 suppliers such as Jaguar Land Rover, Daimler, Samsung SDI & MAHLE. The announcement was made after market hours yesterday, 17 October 2019.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 18 2019 | 8:43 AM IST

Next Story